Publicaciones - TRASPLANTE HEMATOPOYÉTICO / TERAPIA CELULAR

Cargando...

Soler-Espejo E, Marin F, Roldan V, Rivera-Caravaca JM. What is the impact of dynamic score reassessment for stroke and bleeding risk outcome prediction in atrial fibrillation patients? Expert Rev Cardiovasc Ther. 2025 Apr;23(4):107-112. doi: 10.1080/14779072.2025.2489725. Epub 2025 Apr 10. PubMed PMID: 40202395.

AÑO: 2025

40202395

Rivera-Caravaca JM, Menichelli D, Pastori D, Soler-Espejo E, Esteve-Pastor MA, Vivas D, Roldan I, Anguita M, Luis Ferreiro J, Roldan V, Marin F; Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology. Quality of anticoagulation with vitamin K antagonists in Spain: A systematic review with meta-analysis of national registries. Med Clin (Barc). 2025 Jun 3;165(3):107031. doi: 10.1016/j.medcli.2025.107031. Online ahead of print. English, Spanish. PubMed PMID: 40466270.

AÑO: 2025; IF: 2.6

40466270

Gorse L, Plessis L, Wearne S, Paradis M, Pinilla M, Chua R, Lim SS, Pelluz E, Toh GA, Mazars R, Bomfim C, Herve F, Lhaute K, Reveillon D, Suire B, Ravon-Katossky L, Benoist T, Fromont L, Pericat D, Neil Mertens K, Derrien A, Terre-Terrillon A, Chomerat N, Bilien G, Sechet V, Carpentier L, Fall M, Sonko A, Hakim H, Sadio N, Bourdeaux J, Cougoule C, Henras AK, Perez-Oliva AB, Brehmer P, Roca FJ, Zhong FL, Common J, Meunier E, Hess P. Portimine A toxin causes skin inflammation through ZAKalpha-dependent NLRP1 inflammasome activation. EMBO Mol Med. 2025 Mar;17(3):535-562. doi: 10.1038/s44321-025-00197-4. Epub 2025 Feb 13. PubMed PMID: 39948420; PubMed Central PMCID: PMC11903881.

AÑO: 2025; IF: 9.0

39948420

Rivera-Caravaca JM, Soler-Espejo E, Ramos-Bratos MP, Lopez-Galvez R, Gonzalez-Lozano E, Lip GYH, Marin F, Roldan V. The triglyceride-glucose index, a marker of insulin resistance, as a predictor of thrombotic risk in atrial fibrillation. Cardiovasc Diabetol. 2025 Jul 10;24(1):281. doi: 10.1186/s12933-025-02809-2. PubMed PMID: 40640827; PubMed Central PMCID: PMC12247220.

AÑO: 2025; IF: 8.5

40640827

Richardson E, Mo CC, Calabretta E, Corrado F, Kocoglu MH, Baron RM, Connors JM, Iacobelli M, Wei LJ, Benjamin EJ, Rapoport AP, Diaz-Ricart M, Martinez-Mellado AJ, Carlo-Stella C, Richardson PG, Moraleda JM. Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19. Biomolecules. 2025 Jul 14;15(7):1004. doi: 10.3390/biom15071004. PubMed PMID: 40723876; PubMed Central PMCID: PMC12292847.

AÑO: 2025; IF: 4.8

40723876

< Anterior Siguiente >

Publicaciones - TRASPLANTE HEMATOPOYÉTICO / TERAPIA CELULAR

Instituto de Investigación Sanitaria Acreditado

TRASPLANTE HEMATOPOYÉTICO / TERAPIA CELULAR